UBS
-
The Italian Ministry of Economy and Finance has cashed in on a dramatic rebound in MPS since its recapitalisation a year ago
-
Sovereign gets second largest book ever despite political hubbub
-
Swiss pharma company navigates a difficult market to pay a negative to zero new issue premium
-
Investors pounce on Société Générale and UBS sales after yields rise, then rates rally to soothe fears
-
◆ SocGen and especially UBS garner huge demand for high yielding AT1s ◆ Red-hot interest suggests more European banks could issue in subordinated Yankees ◆ HSBC and BBVA raise $2.75bn in tier two
-
A swift combination of the UK investment banking teams of UBS and Credit Suisse shows the rapid progress that has been made, as CEO Sergio Ermotti looks ahead to a ‘pivotal 2024’
-
Kiwi sub-sovereign sacrifices size to price tight
-
Flavour and fragrance company capitalises on investor demand to take size at a tight price
-
◆ Deal marketed at a price to sell ◆ Structure suggests UBS is optimising funding volume ◆ Reluctance to buy Swiss AT1s remains but fixed income markets are recovering
-
Higher rates are powering an equilibrium in the AT1 market that may tempt even the most unlikely of issuers to come to the market
-
Name recognition helps bank go against the grain to tighten pricing
-
Former IB co-CEO to join as vice-chair of corporate and investment bank